V

Vivo Bio Tech Ltd
BSE:511509

Watchlist Manager
Vivo Bio Tech Ltd
BSE:511509
Watchlist
Price: 28.84 INR 2.52% Market Closed
Market Cap: ₹637.4m

Operating Margin

23.4%
Current
Declining
by 0.7%
vs 3-y average of 24.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
23.4%
=
Operating Income
₹117.5m
/
Revenue
₹501.2m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
23.4%
=
Operating Income
₹117.5m
/
Revenue
₹501.2m

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Vivo Bio Tech Ltd
BSE:511509
621.7m INR
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.7B USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385.5B USD
Loading...
CH
Roche Holding AG
SIX:ROG
276.7B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
211.5B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.8B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
271.6B USD
Loading...

Market Distribution

Higher than 85% of companies in India
Percentile
85th
Based on 5 437 companies
85th percentile
23.4%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Vivo Bio Tech Ltd
Glance View

Market Cap
637.4m INR
Industry
N/A

Vivo Bio Tech Ltd. engages in the provision of drug development and discovery services. The company is headquartered in Hyderabad, Telangana. The firm provides services of in-vitro, in-vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. The firm's services are offered to pharma, biotech and Agri companies, which include molecular biology services, the fermentation process of E.Coli harboring the plasmid containing the gene of interest, protein purification, bioassay, Physico-chemical and biochemical/immunological characterization of various proteins. The firm's In-vivo services provide preclinical testing services in rodents/non-rodents, and canines. The firm's subsidiaries include Vivobio Labs Private Ltd, Vivobio Discovery services Private Ltd, Surlogic Life Consultancy Private Ltd and Vivobio Consulting Services Private Ltd.

VIVOBIOT Intrinsic Value
40.43 INR
Undervaluation 29%
Intrinsic Value
Price
V
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
23.4%
=
Operating Income
₹117.5m
/
Revenue
₹501.2m
What is Vivo Bio Tech Ltd's current Operating Margin?

The current Operating Margin for Vivo Bio Tech Ltd is 23.4%, which is below its 3-year median of 24.2%.

How has Operating Margin changed over time?

Over the last 3 years, Vivo Bio Tech Ltd’s Operating Margin has increased from 15.7% to 23.4%. During this period, it reached a low of 12.8% on Dec 31, 2022 and a high of 28.3% on Dec 31, 2023.

Back to Top